Mendeleev Communications
RUS  ENG    JOURNALS   PEOPLE   ORGANISATIONS   CONFERENCES   SEMINARS   VIDEO LIBRARY   PACKAGE AMSBIB  
General information
Latest issue
Archive

Search papers
Search references

RSS
Latest issue
Current issues
Archive issues
What is RSS



Mendeleev Commun.:
Year:
Volume:
Issue:
Page:
Find






Personal entry:
Login:
Password:
Save password
Enter
Forgotten password?
Register


Mendeleev Communications, 2020, Volume 30, Issue 4, Pages 421–423
DOI: https://doi.org/10.1016/j.mencom.2020.07.005
(Mi mendc1210)
 

This article is cited in 13 scientific papers (total in 13 papers)

Communications

Tubulin targeted antimitotic agents based on adamantane lead compound: synthesis, SAR and molecular modeling

N. A. Zefirovab, Yu. A. Evteevaa, A. I. Krasnoperovaa, A. V. Mamaevaa, E. R. Milaevaab, S. A. Kuznetsovc, O. N. Zefirovaab

a Department of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russian Federation
b Institute of Physiologically Active Compounds, Federal Research Center of Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences, Chernogolovka, Moscow Region, Russian Federation
c Institute of Biological Sciences, Cell Biology and Biosystems Technology, University of Rostock, Rostock, Germany
Abstract: 5-Hydroxymethyl-2-methoxyphenyl adamantane-1-acetate inhibits cell proliferation and stimulates depolymerization of microtubules of cancer cells to free tubulin. Its analogues were synthesized via the Steglich or Mitsunobu reactions to determine the role of structural subunits of the molecule in tubulin binding. Based on the structure–activity relationship studies, metabolically stable 1-[2-(5-hydroxymethyl-2-methoxyphenyl)ethyl]adamantane was invented, which exhibits a dual-target profile and retains in vitro activity observed for the lead compound.
Keywords: adamantane, tubulin, colchicine binding site, lung carcinoma A549, dual-target profile, structure–activity relationship.
Bibliographic databases:
Document Type: Article
Language: English
Supplementary materials:
Supplementary_data_1.pdf (886.9 Kb)


Citation: N. A. Zefirov, Yu. A. Evteeva, A. I. Krasnoperova, A. V. Mamaeva, E. R. Milaeva, S. A. Kuznetsov, O. N. Zefirova, “Tubulin targeted antimitotic agents based on adamantane lead compound: synthesis, SAR and molecular modeling”, Mendeleev Commun., 30:4 (2020), 421–423
Linking options:
  • https://www.mathnet.ru/eng/mendc1210
  • https://www.mathnet.ru/eng/mendc/v30/i4/p421
  • This publication is cited in the following 13 articles:
    Citing articles in Google Scholar: Russian citations, English citations
    Related articles in Google Scholar: Russian articles, English articles
    Mendeleev Communications
     
      Contact us:
     Terms of Use  Registration to the website  Logotypes © Steklov Mathematical Institute RAS, 2025